Definitive Healthcare Corp

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Definitive Healthcare reports robust Q4 performance amidst industry challenges

Definitive Healthcare's Q4 2022 performance reflects strong revenue growth and profitability, driven by strategic acquisitions and product innovations, despite economic headwinds.
Challenges such as extended deal cycles and macroeconomic impacts require adaptive strategies, while opportunities in data matching, client growth, and market expansion offer avenues for future success.
The company's focus on cost management, sales enhancements, and long-term growth in the healthcare data market positions it well for sustained performance and industry leadership.
Guidance for Q1 2023 underscores financial stability and growth potential, signaling a proactive approach to navigating challenges and seizing opportunities in the evolving healthcare landscape.

Definitive Healthcare Corp reports solid Q1 results amidst growth strategies

Definitive Healthcare Corp (DH) delivered solid Q1 results amidst challenges, with a focus on enhancing data capabilities and strategic M&A for future growth.
While facing higher churn and margin impacts, the company remains resilient, with stable pricing and a proactive approach to driving performance improvements.
Opportunities lie in acquisitions, cross-selling to existing clients, and maintaining a strong market position through innovation and client value creation.

Definitive Healthcare reports strong Q2 earnings, eyes AI opportunities

Definitive Healthcare's Q2 performance showcased revenue growth, EBITDA margin, and strategic acquisitions, despite workforce reductions and customer declines.
The company's strengths lie in tech investments, market share gains, and cross-sell opportunities, while challenges include workforce reductions and economic uncertainties.
Opportunities in AI advancements, long-term market prospects, and strategic investments position Definitive Healthcare for sustained growth and client value creation.

Definitive Healthcare Corp excels in Q3 amidst market challenges

Definitive Healthcare Corp's Q3 showcased strong financial performance, customer wins, and a focus on innovation despite market challenges.
The company's resilience, marketing effectiveness, and strategies to address churn position it well for future growth and success.
With a commitment to product development, customer engagement, and market leadership, Definitive Healthcare Corp navigates tough market conditions with adaptability.

Definitive Healthcare posts solid Q4 results, eyes growth opportunities in 2024

Definitive Healthcare's Q4 2023 performance was strong, with revenue growth, margin maintenance, and client base expansion.
The company's strategic focus on product investments, customer retention, and innovation positions it well for growth in 2024.
Challenges in the life sciences segment and high M&A valuations are being addressed through strategic initiatives and market positioning.
Opportunities in data asset investment, margin growth, and strong demand present avenues for continued success and expansion.

Definitive Healthcare reports mixed Q1 results, eyes growth opportunities

Definitive Healthcare's Q1 2024 Earnings Call showcased a resilient performance amidst challenges, with a focus on operational excellence and product innovation. Despite facing macroeconomic headwinds and restructuring disruptions, the company remains optimistic about long-term opportunities, driven by improving macro conditions and strategic initiatives.

Definitive Healthcare reports Q2 revenue growth, addresses sales challenges

Definitive Healthcare's Q2 2024 earnings call highlighted mixed performance, with a focus on addressing sales challenges and enhancing operational efficiency. CEO Coop emphasized growth, profitability, and strategic changes to drive shareholder value.

Definitive Healthcare reports Q3 results, plans for growth and efficiency

Definitive Healthcare's Q3 performance showed resilience despite revenue and EBITDA declines, with a strategic focus on simplification and customer success.
While facing challenges like high churn rates, the company aims for future growth through new product offerings and customer expansion.
Opportunities lie in operational efficiency improvements, share buyback program expansion, and strategic product integration for enhanced value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Fourth quarter revenue grew 31% year-over-year to $60.6 million  Full year 2022 revenue grew 34% to $222.7 million

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022

FRAMINGHAM, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its fourth quarter and full year ended December 31, 2022 financial results will be released on Thursday, February 23, 2023, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

Includes reference & affiliation data, all-payor & prescription claims, and medical experts to help clients analyze the healthcare market from nearly any vantage point Includes reference & affiliation data, all-payor & prescription claims, and medical experts to help clients analyze the healthcare market from nearly any vantage point

Definitive Healthcare introduces the Atlas Dataset

60% increase in Atlas Prescription Claims and a significant increase in Atlas All-Payor Claims provides clients with a more in-depth and holistic look at patient care across the healthcare continuum 60% increase in Atlas Prescription Claims and a significant increase in Atlas All-Payor Claims provides clients with a more in-depth and holistic look at patient care across the healthcare continuum

Definitive Healthcare greatly expands all-payor medical and prescription claims coverage

Definitive Healthcare is now down almost 80% from its all-time high in 2021. The healthcare technology company has attractive products and operates in a large and growing market.

Definitive Healthcare: A High Growth Company On Sale

FRAMINGHAM, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Robert Musslewhite, and its Chief Financial Officer, Rick Booth, will present at the 25th Annual Needham Growth Conference.

Definitive Healthcare to Present at the 25th Annual Needham Growth Conference

FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has been named one of the Top Places to Work in Massachusetts by  The Boston Globe . Definitive Healthcare has now been recognized by The Boston Globe for a sixth consecutive year.

Definitive Healthcare named a 2022 Top Place to Work by The Boston Globe for sixth consecutive year

The U.S. healthcare sector has a large industry with many challenges. Definitive Healthcare Corp. has the industry-leading platform.

Definitive Healthcare: A Leader In Its Field, But Valuation Is Rich

Definitive Healthcare Corp. (NASDAQ:DH ) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants David Samuels - Chief Legal Officer Robert Musslewhite - CEO Jason Krantz - Founder & Chairman Rick Booth - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Joe Vruwink - Baird Saket Kalia - Barclays David Grossman - Stifel Maxi Ma - Deutsche Bank Jonathan Yong - Credit Suisse Matt Shea - Needham Johnathan McCary - Raymond James Operator Good morning, afternoon, evening, and welcome to the Definitive Healthcare's Third Quarter 2022 Earnings Call. All participants will be in a listen-only mode.

Definitive Healthcare Corp. (DH) Q3 2022 Earnings Call Transcript

Definitive Healthcare Corp. (DH) delivered earnings and revenue surprises of 20% and 1.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Definitive Healthcare Corp. (DH) Surpasses Q3 Earnings and Revenue Estimates

FRAMINGHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced Jon Maack has joined the company as President, effective November 3, 2022. Maack will report to Definitive Healthcare CEO Robert Musslewhite and have responsibility for product management, engineering, corporate strategy, and M&A.

Definitive Healthcare Names Jon Maack as President Effective November 3, 2022

FRAMINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its third quarter ended September 30, 2022 financial results will be released on Thursday, November 3, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Definitive Healthcare Announces Timing of Its Third Quarter 2022 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has joined the United Nations Global Compact, the largest corporate sustainability initiative in the world.

Definitive Healthcare joins the United Nations Global Compact

Sastry Chilukuri joins Board of Directors and Randy Winn departs Sastry Chilukuri joins Board of Directors and Randy Winn departs

Definitive Healthcare announces changes to Board of Directors

Cinemark Holdings

MeridianLink

Spirit AeroSystems Hlds

Accurately identifying toxic stocks and getting rid of them at the right time can protect your portfolio. It's time to cut ties with toxic stocks like DH, CNK, MLNK and SPR.

4 Toxic Stocks That May Give You a Tough Time

FRAMINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will present at two upcoming conferences: the 2022 Baird Global Healthcare Conference in New York, NY, and the 2022 Goldman Sachs Communacopia + Technology Conference in San Francisco, CA.

Definitive Healthcare to Present at the 2022 Baird Global Healthcare Conference and the 2022 Goldman Sachs Communacopia + Technology Conference

Definitive Healthcare Corp (NASDAQ:DH ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants David Samuels - Chief Legal Officer Robert Musslewhite - President, CEO & Director Jason Krantz - Founder & Executive Chairman Richard Booth - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Maxi Ma - Deutsche Bank David Grossman - Stifel, Nicolaus & Company Jonathan Yong - Crédit Suisse Saket Kalia - Barclays Bank Ryan MacDonald - Needham & Company Operator Good day, and welcome to the Definitive Healthcare Conference Call. [Operator Instructions].

Definitive Healthcare Corp (DH) CEO Robert Musslewhite on Q2 2022 Results - Earnings Call Transcript

Second quarter revenue grew 37% year-over-year to $54.5 million Second quarter revenue grew 37% year-over-year to $54.5 million

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2022

FRAMINGHAM, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder and Executive Chairman, Jason Krantz, its Chief Executive Officer, Robert Musslewhite, and its Chief Financial Officer, Rick Booth, will present at the Canaccord Genuity 42nd Annual Growth Conference.

Definitive Healthcare to Present at the Canaccord Genuity 42nd Annual Growth Conference

New product integrates comprehensive analytics built by Analytical Wizards with industry-leading data from Definitive Healthcare in a single package for more than 20 therapy areas New product integrates comprehensive analytics built by Analytical Wizards with industry-leading data from Definitive Healthcare in a single package for more than 20 therapy areas

Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma

FRAMINGHAM, Mass., July 14, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its second quarter ended June 30, 2022 financial results will be released on Thursday, August 4, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Definitive Healthcare Announces Timing of Its Second Quarter 2022 Financial Results Conference Call and Webcast

Medical affairs teams can now access the scientific activities of nearly 13 million experts globally across all therapeutic areas in a single platform Medical affairs teams can now access the scientific activities of nearly 13 million experts globally across all therapeutic areas in a single platform

Definitive Healthcare launches Monocl ExpertInsight 2.0 and ExpertGO mobile app

Definitive Healthcare has done quite alright, the business that is, since its IPO last year. The company sees solid topline sales traction and is posting largely break-even results on the bottom line.

Definitive Healthcare: No Involvement Yet Here

FRAMINGHAM, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder and Chief Executive Officer, Jason Krantz, its Chief Financial Officer, Rick Booth, and its President, Robert Musslewhite, will present at the Stifel 2022 Cross Sector Insight Conference.

Definitive Healthcare to Present at the Stifel 2022 Cross Sector Insight Conference

FRAMINGHAM, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- In a previous version of this release issued earlier today by Definitive Healthcare Corp. (Nasdaq: DH), the date of the presentation was Monday, May 23, 2022 at 9:20 a.m. ET. The correct presentation date is Wednesday, May 25th at 10:00 a.m. ET. The updated release reads:

News for Definitive Healthcare Corp Stock (DH)